ACC/AHA TASK FORCE ON PERFORMANCE MEASURES Gregg C. Fonarow, MD, FACC, FAHA, Chair; Paul A. Heidenreich, MD, MS, FACC, FAHA, Immediate Past Chair; Nancy M. Albert, PhD, CCNS, CCRN, FAHA ; Geoffrey D. Barnes, MD, MSc, FACC ; Paul S. Chan, MD, MSc, FACC ; Lesley H. Curtis, PhD ; Lauren Gilstrap, MD ; Michelle Gurvitz, MD, FACC ; P. Michael Ho, MD, PhD, FACC, FAHA ; Corrine Y. Jurgens, PhD, RN, ANP-BC, FAHA ; Sean O Brien, PhD ; Jeffrey Olin, DO, FACC, FAHA ; Tiffany Randolph, MD ; Andrea M. Russo, MD, FACC ; Randal J. Thomas, MD, FACC, FAHA ; Paul D. Varosy, MD, FACC ; Robert Yeh, MD, FACC ; Samad Zaheeruddin, MD 2017 by the American Heart Association, Inc., and the American College of Cardiology Foundation. Circ Cardiovasc Qual Outcomes is available at http://circoutcomes.ahajournals.org DOI: 10.1161/HCQ.0000000000000032 *ACC/AHA Task Force on Performance Measures Liaison. Society for Cardiovascular Angiography and Interventions Representative. American College of Cardiology Representative. American Heart Association Representative. The American Heart Association and the American College of Cardiology make every effort to avoid any actual or potential conflicts of interest that may arise as a result of an outside relationship or a personal, professional, or business interest of a member of the writing panel. Specifically, all members of the writing group are required to complete and submit a Disclosure Questionnaire showing all such relationships that might be perceived as real or potential conflicts of interest. This document was approved by the American College of Cardiology Clinical Policy Approval Committee on May 22, 2017, the American Heart Association Science Advisory and Coordinating Committee on June 7, 2017, the American Heart Association Executive Committee on August 11, 2017, and the Society for Cardiovascular Angiography and Interventions on July 17, 2017. 